Healthy men test new drug MTX-463 in early safety trial
NCT ID NCT07450521
First seen Mar 05, 2026 · Last updated May 18, 2026 · Updated 10 times
Summary
This early-stage study tested the safety and how the body processes a new drug called MTX-463 in 8 healthy adult men. Participants received either the drug or a placebo by injection. The goal was to gather safety information and measure drug levels in the blood, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Icon Slc Cru
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.